Date published: 2026-3-9

1-800-457-3801

SCBT Portrait Logo
Seach Input

COG5 Inhibitors

COG5 inhibitors encompass a specialized group of chemical compounds designed to interfere with the activity of the COG5 protein, a component of the conserved oligomeric Golgi (COG) complex. This complex is essential for normal Golgi function and vesicular trafficking processes. Inhibition of COG5 can disrupt the delicate balance of protein sorting and glycosylation, leading to a cascade of effects within the cell. The chemical inhibitors targeting COG5 typically function by either directly binding to the protein, obstructing its interaction with other COG complex components, or by destabilizing the overall structure of the complex, which results in diminished function. As COG5 plays a critical role in maintaining Golgi structure and function, these inhibitors effectively induce a state of Golgi stress. This stress can lead to a series of intracellular responses, including activation of signaling pathways related to the unfolded protein response and potentially influencing the glycosylation patterns of proteins destined for the cell surface or secretion.

The molecular action of COG5 inhibitors is highly specific, exploiting the unique properties of the COG5 protein within the context of the COG complex. By targeting COG5, these inhibitors can indirectly affect various glycosyltransferases and glycosidases that are critical for proper oligosaccharide processing and assembly. The perturbation caused by COG5 inhibition can result in the improper modification of proteins, which may affect protein stability, localization, and function, providing insight into the fundamental mechanisms of Golgi-mediated protein processing. It is the precision of this disruption that highlights the specificity of COG5 inhibitors. Unlike broad-spectrum inhibitors that can indiscriminately affect multiple proteins or pathways, COG5 inhibitors are tailored to modulate the function of this specific protein within its native complex, leading to predictable and targeted outcomes within the cells. This specificity underscores the utility of COG5 inhibitors as molecular tools in dissecting the roles of COG5 and the COG complex in cellular biology and the fundamental importance of Golgi function in cell physiology.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$31.00
$53.00
$124.00
$374.00
25
(3)

Inhibits the ADP-ribosylation factor (ARF), a small GTPase involved in vesicle formation at the Golgi complex, thereby disrupting the COG (Conserved Oligomeric Golgi) complex's function, including COG5, in maintaining Golgi structure and trafficking.

Monensin A

17090-79-8sc-362032
sc-362032A
5 mg
25 mg
$155.00
$525.00
(1)

A polyether antibiotic that disrupts Golgi function by altering the Golgi pH and cation gradients, indirectly inhibiting COG5's role in glycoprotein modification and transport.

Nocodazole

31430-18-9sc-3518B
sc-3518
sc-3518C
sc-3518A
5 mg
10 mg
25 mg
50 mg
$59.00
$85.00
$143.00
$247.00
38
(2)

Microtubule depolymerizer that indirectly affects COG5 by disrupting microtubule-dependent trafficking to and from the Golgi apparatus, where COG5 exerts its function.

Golgicide A

1005036-73-6sc-215103
sc-215103A
5 mg
25 mg
$191.00
$683.00
11
(1)

Specifically targets the Golgi BFA resistance factor 1 (GBF1), a GEF for ARF, leading to Golgi disruption and indirect inhibition of COG5's function in Golgi maintenance and protein trafficking.

Tyrphostin AG 1478

175178-82-2sc-200613
sc-200613A
5 mg
25 mg
$96.00
$421.00
16
(1)

An EGFR tyrosine kinase inhibitor that can indirectly affect COG5 by downregulating signaling pathways involved in Golgi apparatus function and vesicular trafficking.

Tunicamycin

11089-65-9sc-3506A
sc-3506
5 mg
10 mg
$172.00
$305.00
66
(3)

An antibiotic that inhibits N-linked glycosylation in the ER, leading to ER stress and potential indirect impairment of COG5-related functions due to disruption of ER-Golgi trafficking.

Castanospermine

79831-76-8sc-201358
sc-201358A
100 mg
500 mg
$184.00
$632.00
10
(1)

A glucosidase inhibitor that interferes with N-glycan processing in the ER and Golgi, potentially hindering COG5's role in glycoprotein modification and transport.

Swainsonine

72741-87-8sc-201362
sc-201362C
sc-201362A
sc-201362D
sc-201362B
1 mg
2 mg
5 mg
10 mg
25 mg
$138.00
$251.00
$631.00
$815.00
$1832.00
6
(1)

Inhibits Golgi alpha-mannosidase II, leading to the accumulation of misprocessed glycoproteins and indirectly affecting COG5's function in glycoprotein trafficking.

Deoxynojirimycin

19130-96-2sc-201369
sc-201369A
1 mg
5 mg
$73.00
$145.00
(0)

A glucosidase inhibitor that might disrupt the normal glycoprotein processing within the Golgi apparatus, indirectly impacting COG5's function in maintaining Golgi structure and protein trafficking.

Colchicine

64-86-8sc-203005
sc-203005A
sc-203005B
sc-203005C
sc-203005D
sc-203005E
1 g
5 g
50 g
100 g
500 g
1 kg
$100.00
$321.00
$2289.00
$4484.00
$18207.00
$34749.00
3
(2)

By binding to tubulin, colchicine prevents microtubule polymerization, affecting vesicle transport processes to and from the Golgi, thus indirectly impairing COG5's role in these processes.